There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K35/17
Subcategories
This category has the following 7 subcategories, out of 7 total.
E
G
H
J
R
S
W
Pages in category "A61K35/17"
The following 37 pages are in this category, out of 37 total.
1
- 18065451. ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY simplified abstract (Board of Regents, The University of Texas System)
- 18224865. GENERATION OF ANTI-TUMOR T CELLS simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18260377. ANTI-CD72 NANOBODIES FOR IMMUNOTHERAPY simplified abstract (The Regents of the University of California)
- 18274145. TREATMENT OF NEUROENDOCRINE CANCERS (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18274979. IMMUNE RECEPTORS WITH SYNTHETIC CO-STIMULATORY DOMAINS simplified abstract (The Regents of the University of California)
- 18295036. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation)
- 18373569. GENETICALLY MODIFIED GENES AND CELLS, AND METHODS OF USING SAME FOR SILENCING VIRUS GENE EXPRESSION simplified abstract (Wisconsin Alumni Research Foundation)
- 18381258. CAR-T CONSTRUCTS COMPRISING A NOVEL CD19 BINDER COMBINED WITH IL18 AND METHODS OF USING THE SAME simplified abstract (The Trustees of the University of Pennsylvania)
- 18393997. Methods and Products for Reducing HIV Reservoirs simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18454684. CHIMERIC ANTIGEN RECEPTORS THAT BIND PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME)/HLA-A2 TO TREAT CANCER simplified abstract (Fred Hutchinson Cancer Center)
- 18482223. HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18558882. DOUBLE SIDED CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED CELL MEMBRANE BASED DRUG DELIVERY SYSTEMS simplified abstract (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM)
- 18620748. Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias simplified abstract (The Trustees of the University of Pennsylvania)
- 18621640. COMPOSITIONS AND METHODS FOR MODULATING T CELL RESPONSES (The Regents of the University of California)
- 18643312. BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract (The Regents of the University of California)
- 18647560. SYSTEMS AND METHODS TO IDENTIFY MHC-ASSOCIATED ANTIGENS FOR THERAPEUTIC INTERVENTION simplified abstract (GENENTECH, INC.)
- 18750233. ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF simplified abstract (Board of Regents, The University of Texas System)
B
T
- The regents of the university of california (20240261334). BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract
- The regents of the university of california (20240262882). NOVEL RECEPTORS FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION simplified abstract
- The regents of the university of california (20240293463). BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract
- The regents of the university of california (20240299449). ANTI-CD72 NANOBODIES FOR IMMUNOTHERAPY simplified abstract
- The regents of the university of california (20240408137). METHODS FOR MAKING AND USING THERAPEUTIC CELLS
- The regents of the university of california (20250115652). COMPOSITIONS AND METHODS FOR MODULATING T CELL RESPONSES
- The Regents of the University of California patent applications on April 10th, 2025
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on August 8th, 2024
- The Regents of the University of California patent applications on December 12th, 2024
- The Regents of the University of California patent applications on September 12th, 2024
- The Regents of the University of California patent applications on September 5th, 2024